Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism.
Chronic lymphocytic leukemia (CLL) is an adult B cell malignancy. Genome-wide association studies show that variation at 15q15.1 influences CLL risk. We deciphered the causal variant at 15q15.1 and the mechanism by which it influences tumorigenesis. We imputed all possible genotypes across the locus...
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2017
|
| _version_ | 1797063522614509568 |
|---|---|
| author | Kandaswamy, R Sava, G Speedy, H Beà, S Martín-Subero, J Studd, J Migliorini, G Law, P Puente, X Martín-García, D Salaverria, I Gutiérrez-Abril, J López-Otín, C Catovsky, D Allan, J Campo, E Houlston, R |
| author_facet | Kandaswamy, R Sava, G Speedy, H Beà, S Martín-Subero, J Studd, J Migliorini, G Law, P Puente, X Martín-García, D Salaverria, I Gutiérrez-Abril, J López-Otín, C Catovsky, D Allan, J Campo, E Houlston, R |
| author_sort | Kandaswamy, R |
| collection | OXFORD |
| description | Chronic lymphocytic leukemia (CLL) is an adult B cell malignancy. Genome-wide association studies show that variation at 15q15.1 influences CLL risk. We deciphered the causal variant at 15q15.1 and the mechanism by which it influences tumorigenesis. We imputed all possible genotypes across the locus and then mapped highly associated SNPs to areas of chromatin accessibility, evolutionary conservation, and transcription factor binding. SNP rs539846 C>A, the most highly associated variant (p = 1.42 × 10(-13), odds ratio = 1.35), localizes to a super-enhancer defined by extensive histone H3 lysine 27 acetylation in intron 3 of B cell lymphoma 2 (BCL2)-modifying factor (BMF). The rs539846-A risk allele alters a conserved RELA-binding motif, disrupts RELA binding, and is associated with decreased BMF expression in CLL. These findings are consistent with rs539846 influencing CLL susceptibility through differential RELA binding, with direct modulation of BMF expression impacting on anti-apoptotic BCL2, a hallmark of oncogenic dependency in CLL. |
| first_indexed | 2024-03-06T21:01:06Z |
| format | Journal article |
| id | oxford-uuid:3ae750cb-74b4-49f4-b7d2-8960f1f7cb94 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T21:01:06Z |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:3ae750cb-74b4-49f4-b7d2-8960f1f7cb942022-03-26T14:04:27ZGenetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3ae750cb-74b4-49f4-b7d2-8960f1f7cb94EnglishSymplectic Elements at OxfordElsevier2017Kandaswamy, RSava, GSpeedy, HBeà, SMartín-Subero, JStudd, JMigliorini, GLaw, PPuente, XMartín-García, DSalaverria, IGutiérrez-Abril, JLópez-Otín, CCatovsky, DAllan, JCampo, EHoulston, RChronic lymphocytic leukemia (CLL) is an adult B cell malignancy. Genome-wide association studies show that variation at 15q15.1 influences CLL risk. We deciphered the causal variant at 15q15.1 and the mechanism by which it influences tumorigenesis. We imputed all possible genotypes across the locus and then mapped highly associated SNPs to areas of chromatin accessibility, evolutionary conservation, and transcription factor binding. SNP rs539846 C>A, the most highly associated variant (p = 1.42 × 10(-13), odds ratio = 1.35), localizes to a super-enhancer defined by extensive histone H3 lysine 27 acetylation in intron 3 of B cell lymphoma 2 (BCL2)-modifying factor (BMF). The rs539846-A risk allele alters a conserved RELA-binding motif, disrupts RELA binding, and is associated with decreased BMF expression in CLL. These findings are consistent with rs539846 influencing CLL susceptibility through differential RELA binding, with direct modulation of BMF expression impacting on anti-apoptotic BCL2, a hallmark of oncogenic dependency in CLL. |
| spellingShingle | Kandaswamy, R Sava, G Speedy, H Beà, S Martín-Subero, J Studd, J Migliorini, G Law, P Puente, X Martín-García, D Salaverria, I Gutiérrez-Abril, J López-Otín, C Catovsky, D Allan, J Campo, E Houlston, R Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title | Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title_full | Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title_fullStr | Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title_full_unstemmed | Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title_short | Genetic predisposition to chronic lymphocytic leukemia is mediated by a BMF super-enhancer polymorphism. |
| title_sort | genetic predisposition to chronic lymphocytic leukemia is mediated by a bmf super enhancer polymorphism |
| work_keys_str_mv | AT kandaswamyr geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT savag geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT speedyh geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT beas geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT martinsuberoj geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT studdj geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT migliorinig geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT lawp geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT puentex geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT martingarciad geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT salaverriai geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT gutierrezabrilj geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT lopezotinc geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT catovskyd geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT allanj geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT campoe geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism AT houlstonr geneticpredispositiontochroniclymphocyticleukemiaismediatedbyabmfsuperenhancerpolymorphism |